Journal of Skin Cancer最新文献

筛选
英文 中文
Erratum to “Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information” “基底细胞癌病理要求和报告缺乏重要信息”的勘误
IF 1.1
Journal of Skin Cancer Pub Date : 2019-07-14 DOI: 10.1155/2019/6846428
Firas A. Al-qarqaz, K. Bodoor, A. Al-Tarawneh, H. Eloqayli, Wisam Al Gargaz, D. Alshiyab, J. Muhaidat, M. Alqudah, R. Almomani, Maha Marji
{"title":"Erratum to “Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information”","authors":"Firas A. Al-qarqaz, K. Bodoor, A. Al-Tarawneh, H. Eloqayli, Wisam Al Gargaz, D. Alshiyab, J. Muhaidat, M. Alqudah, R. Almomani, Maha Marji","doi":"10.1155/2019/6846428","DOIUrl":"https://doi.org/10.1155/2019/6846428","url":null,"abstract":"[This corrects the article DOI: 10.1155/2019/4876309.].","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2019-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85917590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients 面部关键部位非黑色素瘤皮肤癌:102例手术治疗的结果和策略
IF 1.1
Journal of Skin Cancer Pub Date : 2019-06-26 DOI: 10.1155/2019/4798510
Carlos Alberto Ferreira de Freitas, Andreza Negreli Santos, Guilherme Canho Bittner, Baltazar Dias Sanabria, M. M. M. D. Levenhagen, Günther Hans-Filho
{"title":"Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients","authors":"Carlos Alberto Ferreira de Freitas, Andreza Negreli Santos, Guilherme Canho Bittner, Baltazar Dias Sanabria, M. M. M. D. Levenhagen, Günther Hans-Filho","doi":"10.1155/2019/4798510","DOIUrl":"https://doi.org/10.1155/2019/4798510","url":null,"abstract":"Background To evaluate the surgical treatment results of a consecutive series of patients with nonmelanoma skin cancer in critical facial regions such as the nose, lip, eyelid, ear, forehead, cheek, and chin. Methods This was a prospective observational cohort study evaluating the surgical treatment results of 102 patients with nonmelanoma skin cancer who underwent surgical excision and required some type of reconstruction. The reconstruction strategy used, histological type and margins, aesthetic result, and complications were evaluated. Results The most common facial site was the nose (48.01%), followed by the eyelid, ear, cheek, forehead, and lip. The most frequently used type of reconstruction was the advancement flap (30.39%), followed by transposition flap (27,45%), rotation flap (14.70%), and grafts (10.78%). Basal cell carcinoma was the most frequent histological type, accounting for 90.19% of the sample, with 54.90% of these cases being of the nodular subtype. Disease-free margins were obtained in 94.11% of the patients, and only one patient presented compromised margins and underwent marginal extension. A good cosmetic result was found in 93.13% of the participants. Conclusion Surgical treatment can provide excellent oncological, functional, and cosmetic results in the treatment of patients with nonmelanoma skin cancer at critical facial sites.","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2019-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77319816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Sternectomy for Treating Advanced Non-Melanoma Skin Cancer. 胸骨切除术治疗晚期非黑色素瘤皮肤癌。
IF 1.1
Journal of Skin Cancer Pub Date : 2019-05-30 eCollection Date: 2019-01-01 DOI: 10.1155/2019/3948782
Victor Emmanuel Gadelha Pinheiro, Bianca Rohsner Bezerra, Luís Arthur Brasil Gadelha Farias, Irapuan Teles de Araujo Filho, Marcio Ribeiro Studart da Fonseca
{"title":"Sternectomy for Treating Advanced Non-Melanoma Skin Cancer.","authors":"Victor Emmanuel Gadelha Pinheiro,&nbsp;Bianca Rohsner Bezerra,&nbsp;Luís Arthur Brasil Gadelha Farias,&nbsp;Irapuan Teles de Araujo Filho,&nbsp;Marcio Ribeiro Studart da Fonseca","doi":"10.1155/2019/3948782","DOIUrl":"https://doi.org/10.1155/2019/3948782","url":null,"abstract":"<p><strong>Introduction: </strong>Skin cancer is a rare indication of sternectomy. Our goal is to report the clinical course of seven patients who underwent sternectomy for skin cancer.</p><p><strong>Methods: </strong>The survey data were collected from medical records of patients treated between 2008 and 2018 at Ceará Cancer Institute.</p><p><strong>Results: </strong>All patients had prolonged sunlight exposure and average disease time of two years and age of 60 years. Most patients recovered favorably after treatment with prolonged survival.</p><p><strong>Conclusion: </strong>Sternectomy remains an option with curative purposes for locally advanced skin cancer.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2019-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/3948782","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37391481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Immunohistochemical Analysis of BRAF (V600E) Mutation and P16 Expression in Malignant Melanoma in Lagos, Nigeria: A 10-Year Retrospective Study. 尼日利亚拉各斯地区恶性黑色素瘤中BRAF (V600E)突变和P16表达的免疫组化分析:一项10年回顾性研究
IF 1.1
Journal of Skin Cancer Pub Date : 2019-04-17 eCollection Date: 2019-01-01 DOI: 10.1155/2019/1628247
O Obadofin, K Badmos, N Orsi, M Bipin, O Rotimi, A Banjo
{"title":"Immunohistochemical Analysis of BRAF (V600E) Mutation and P16 Expression in Malignant Melanoma in Lagos, Nigeria: A 10-Year Retrospective Study.","authors":"O Obadofin,&nbsp;K Badmos,&nbsp;N Orsi,&nbsp;M Bipin,&nbsp;O Rotimi,&nbsp;A Banjo","doi":"10.1155/2019/1628247","DOIUrl":"https://doi.org/10.1155/2019/1628247","url":null,"abstract":"<p><strong>Background: </strong>In Blacks, malignant melanoma (MM) is associated with greater morbidity and mortality compared to Caucasians. MMs with BRAF V600E mutation as well as those with loss of p16 protein expression are associated with aggressive behavior and worse prognosis.</p><p><strong>Objectives: </strong>We determined BRAF (V600E) mutation status and loss of p16 expression in MM cases in Lagos, Nigeria, and correlated these with histopathologic parameters and patients' age.</p><p><strong>Methods: </strong>Forty-five cases of MM received between January 2005 and December 2014 in the Anatomic and Molecular Pathology Department of Lagos University Teaching Hospital were subjected to immunohistochemical studies to determine BRAF V600E mutation and p16 protein expression. These included cutaneous (<i>n</i>=37), musosal (<i>n</i>=3), and ocular MM (<i>n</i>=2) as well as lymph node metastatases (<i>n</i>=3).</p><p><strong>Results: </strong>BRAF (V600E) mutations were detected in 5/45 (11%) while 31/45 (69%) of the cases had loss of p16 expression. No statistically significant association was found between the BRAF (V600E) mutation, loss of p16 expression, and histologic parameters such as histologic variant, Clark level, Breslow thickness, and ulceration.</p><p><strong>Conclusion: </strong>BRAF (V600E) mutation was detected only in a small proportion of cases while loss of p16 expression occurred in most cases which also had high Clark level, high Breslow thickness, and ulceration.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/1628247","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37281440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation. 肺移植后发生非黑色素瘤皮肤癌的危险因素。
IF 1.1
Journal of Skin Cancer Pub Date : 2019-03-10 eCollection Date: 2019-01-01 DOI: 10.1155/2019/7089482
Nikolai Gräger, Mareike Leffler, Jens Gottlieb, Jan Fuge, Gregor Warnecke, Ralf Gutzmer, Imke Satzger
{"title":"Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation.","authors":"Nikolai Gräger,&nbsp;Mareike Leffler,&nbsp;Jens Gottlieb,&nbsp;Jan Fuge,&nbsp;Gregor Warnecke,&nbsp;Ralf Gutzmer,&nbsp;Imke Satzger","doi":"10.1155/2019/7089482","DOIUrl":"https://doi.org/10.1155/2019/7089482","url":null,"abstract":"<p><strong>Background: </strong>Nonmelanoma skin cancer (NSMC) is the most common malignancy after organ transplantation. Lung transplant recipients (LTRs) are particularly prone to develop NMSC as compared to renal or hepatic transplant recipients due to higher dosages of immunosuppression needed. Everolimus, an immunosuppressant used in organ transplant recipients, is thought to inherit a lower risk for NMSC than calcineurin inhibitors, especially in renal transplant recipients. It is currently unknown whether this also applies to LTRs.</p><p><strong>Objectives: </strong>To determine risk factors for NMSC and precancerous lesions after lung transplantation (LTx) and to characterize the effect of everolimus-based regimens regarding this risk.</p><p><strong>Materials and methods: </strong>90 LTRs and former participants of the interventional trial \"Immunosuppressive Therapy with Everolimus after Lung Transplantation\", who were randomized to receive either an everolimus- or mycophenolate mofetil- (MMF-) based regimen, were enrolled and screened in this retrospective, single-center cohort study.</p><p><strong>Results: </strong>After a median follow-up of 101 months, we observed a prevalence of 38% for NMSC or precancerous lesions. 33% of the patients continuously receiving everolimus from LTx to dermatologic examination compared to 39% of all other patients, predominantly receiving an MMF-based regimen, were diagnosed with at least one NMSC or precancerous lesion (<i>P=</i>.66). Independent risk factors for NMSC or precancerous lesions after LTx were male sex and duration of voriconazole therapy.</p><p><strong>Conclusion: </strong>NMSC or precancerous lesions were very common after LTx, and risk factors were similar to previous reports on LTRs. Everolimus did not decrease this risk under the given circumstances of this study. Patients should be counseled regarding their risk, perform vigorous sunscreen, and undergo regular dermatological controls, regardless of their immunosuppressive regimen.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2019-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/7089482","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37328347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information. 基底细胞癌病理要求和报告缺乏重要信息。
IF 1.1
Journal of Skin Cancer Pub Date : 2019-01-03 eCollection Date: 2019-01-01 DOI: 10.1155/2019/4876309
Firas Al-Qarqaz, Khaldon Bodoor, Awad Al-Tarawneh, Haytham Eloqayli, Wisam Al Gargaz, Diala Alshiyab, Jihan Muhaidat, Mohammad Alqudah, Rowida Almomani, Maha Marji
{"title":"Basal Cell Carcinoma Pathology Requests and Reports Are Lacking Important Information.","authors":"Firas Al-Qarqaz,&nbsp;Khaldon Bodoor,&nbsp;Awad Al-Tarawneh,&nbsp;Haytham Eloqayli,&nbsp;Wisam Al Gargaz,&nbsp;Diala Alshiyab,&nbsp;Jihan Muhaidat,&nbsp;Mohammad Alqudah,&nbsp;Rowida Almomani,&nbsp;Maha Marji","doi":"10.1155/2019/4876309","DOIUrl":"https://doi.org/10.1155/2019/4876309","url":null,"abstract":"<p><strong>Introduction: </strong>Basal cell carcinoma (BCC) is the most common cancer affecting humans. Luckily it has negligible risk for metastasis; however it can be locally destructive to surrounding tissue. The diagnosis of this tumor relies on clinical and dermoscopic features; however confirmation requires biopsy and histologic examination. Based on clinical and pathologic findings, BCC is classified as low or high risk subtype. The clinician requesting pathology examination for BCC should provide the pathologist with detailed information including patient details, relevant clinical and medical history, site and type of the biopsy, and whether this is a primary or recurrent lesion. The pathologist on the other hand should write an adequate report containing a minimum of core set of parameters including type of BCC, depth of invasion, presence of lymphovascular or perineural invasion, and the excision margins.</p><p><strong>Objectives: </strong>The objective of this study is to evaluate whether requests by clinicians and pathology reports of BCC are adequate.</p><p><strong>Methods: </strong>This is a retrospective analysis done at the dermatology department, faculty of medicine at Jordan University of Science and Technology, Irbid, Jordan. Reports for the period from January 2003 to December 2017 were retrieved and analyzed for data completeness.</p><p><strong>Results: </strong>Most clinical request forms of BCC provided by clinicians are inadequate and lack important relevant information especially in regard to lesion history, patient medical history, and whether BCC is a primary or a recurrent one. Pathology reports for BCC cases also have significant deficiency especially in describing the histologic subtype, depth of invasion, and presence of lymphovascular and perineural invasion. However, the tumor excision margins are adequately described in almost all reports.</p><p><strong>Conclusions: </strong>The study shows that clinicians do not provide adequate clinical information when submitting a request for histopathologic examination of BCC. Similarly, pathologists write incomplete reports that lack important pathologic features. Having pre-set forms (electronic proforma) can help overcome missing information.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2019-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/4876309","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36977203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Clinical and Demographic Features of Basal Cell Carcinoma in North Jordan. 北约旦基底细胞癌的临床和人口学特征。
IF 1.1
Journal of Skin Cancer Pub Date : 2018-10-04 eCollection Date: 2018-01-01 DOI: 10.1155/2018/2624054
Firas Al-Qarqaz, Maha Marji, Khaldon Bodoor, Rowida Almomani, Wisam Al Gargaz, Diala Alshiyab, Jihan Muhaidat, Mohammad Alqudah
{"title":"Clinical and Demographic Features of Basal Cell Carcinoma in North Jordan.","authors":"Firas Al-Qarqaz,&nbsp;Maha Marji,&nbsp;Khaldon Bodoor,&nbsp;Rowida Almomani,&nbsp;Wisam Al Gargaz,&nbsp;Diala Alshiyab,&nbsp;Jihan Muhaidat,&nbsp;Mohammad Alqudah","doi":"10.1155/2018/2624054","DOIUrl":"https://doi.org/10.1155/2018/2624054","url":null,"abstract":"<p><p>Basal cell carcinoma (BCC) is the most common cancer affecting humans. It almost has no tendency for metastasis; however it can be destructive to surrounding tissue. Patients with darker skin colors have lower risk of developing skin cancers and the clinical characteristics may differ from populations with lighter skin colors. <i>Methods</i>. This is a retrospective clinical study (2003-2017). Data on age, gender, and location of tumor were collected and analyzed. <i>Results</i>. 335 cases were identified. Males tend to get BCC at a younger age than females. Face was the most common site in both males and females. Cheeks and nose were the most likely areas of the face to be involved. Scalp was the most common extrafacial site to be involved in males; however in females scalp was much less likely to be involved. <i>Conclusion</i>. BCC is less common in populations with darker skin. Males were more affected and at an earlier age compared to females. Facial skin followed by scalp was the most common site affected. Skin phototype, cultural and religious dress type, and different sun exposure behavior may explain many of the clinical and demographic findings related to BCC in patients with darker skin tones.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2018-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/2624054","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36737637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Basosquamous Carcinoma: A Single Centre Clinicopathological Evaluation and Proposal of an Evidence-Based Protocol. 基底鳞状癌:单中心临床病理评估和循证方案建议。
IF 1.1
Journal of Skin Cancer Pub Date : 2018-06-03 eCollection Date: 2018-01-01 DOI: 10.1155/2018/6061395
Jordan W Oldbury, Richard A J Wain, Sameera Abas, Christopher M Dobson, Srinivasan S Iyer
{"title":"Basosquamous Carcinoma: A Single Centre Clinicopathological Evaluation and Proposal of an Evidence-Based Protocol.","authors":"Jordan W Oldbury,&nbsp;Richard A J Wain,&nbsp;Sameera Abas,&nbsp;Christopher M Dobson,&nbsp;Srinivasan S Iyer","doi":"10.1155/2018/6061395","DOIUrl":"https://doi.org/10.1155/2018/6061395","url":null,"abstract":"<p><p>Basosquamous carcinoma (BSC) is an uncommon skin malignancy with significant invasive and metastatic potential. There are currently no clear management guidelines. This study evaluates the management and outcomes of patients diagnosed with BSC over a 7-year period. We present an evidence-based unit protocol for the management of BSC. All patients treated for BSC between 2009 and 2015 were reviewed. Data collected included patient demographics, tumour-specific information, management strategy, presence of recurrence or metastasis, and details of follow-up. 74 patients were identified, making this one of the largest cohorts of BSC patients reported. Mean age at diagnosis was 75.4 years, with a male:female ratio of 1.6:1. The most common tumour site was the head and neck (n=43, 58.1%). All tumours were graded at pT1 (n=51) or pT2 (n=23). Inadequate excision occurred in 17 patients (23%). Mean excision margins were >4mm peripherally and deep. Inadequately excised BSCs were further treated with wide local excision (n=6) or radiotherapy (n=5), or both (n=1). There were no cases of local recurrence or metastatic disease. This study demonstrates a cohort of patients with BSCs that appear less aggressive than previously reported. Current management with surgical excision appears to produce adequate results. However, an evidence-based guideline is still lacking.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2018-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/6061395","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36285518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Essential Components of Melanoma Histopathological Reporting: The Surgical Oncologist's Perspective. 黑色素瘤组织病理学报告的基本组成部分:外科肿瘤学家的观点。
IF 1.1
Journal of Skin Cancer Pub Date : 2018-05-02 eCollection Date: 2018-01-01 DOI: 10.1155/2018/9838410
Vinka Nurdjaja, Masato Yozu, Jon A Mathy
{"title":"Essential Components of Melanoma Histopathological Reporting: The Surgical Oncologist's Perspective.","authors":"Vinka Nurdjaja, Masato Yozu, Jon A Mathy","doi":"10.1155/2018/9838410","DOIUrl":"10.1155/2018/9838410","url":null,"abstract":"<p><p>Histopathological reporting plays a critical role in guiding the surgical oncologist's management plan in treatment of primary cutaneous melanoma. The International Collaboration on Cancer Reporting (ICCR) espouses various components of structured histopathological reporting as \"essential\" or \"recommended.\" From a surgical oncologist's perspective, we discuss the clinical relevance of each essential component, as well as prognostic and treatment implications with regard to treatment planning.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2018-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/9838410","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36181906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Predictors of Sun Protective Behaviors among Latino Day Laborers. 拉丁裔日工防晒行为的预测因素。
IF 1.1
Journal of Skin Cancer Pub Date : 2018-01-28 eCollection Date: 2018-01-01 DOI: 10.1155/2018/3454309
Javier F Boyas, Vinayak K Nahar
{"title":"Predictors of Sun Protective Behaviors among Latino Day Laborers.","authors":"Javier F Boyas,&nbsp;Vinayak K Nahar","doi":"10.1155/2018/3454309","DOIUrl":"https://doi.org/10.1155/2018/3454309","url":null,"abstract":"<p><strong>Objectives: </strong>Despite the substantial solar ultraviolet radiation experienced by Latino day laborers, little attention has been given to factors that are associated with sun protective behaviors. The purpose of this study was to examine psychological and nonpsychological predictors of sun protective behaviors among Latino day laborers.</p><p><strong>Methods: </strong>This cross-sectional study included a nonrandom sample of 137 Latino day laborers recruited from Mississippi and Illinois. Participants completed a self-report survey instrument, available in English and Spanish, on sun protective behaviors.</p><p><strong>Results: </strong>Multivariate regression results showed that sun protective behaviors were significantly greater among Latino day laborers: (a) who had greater perceptions that their supervisor also engaged in sun protective behaviors (<i>β</i> = 0.25, <i>p</i> ≤ 0.01); (b) who reported higher levels of health literacy (<i>β</i> = 0.23, <i>p</i> ≤ 0.001); (c) who have greater knowledge of skin cancer risk factors (<i>β</i> = 0.21, <i>p</i> ≤ 0.01); and (d) who have skin tone that was self-perceived to be more prone to sunburns (<i>β</i> = 0.19, <i>p</i> ≤ 0.01).</p><p><strong>Conclusions: </strong>Latino day laborers possess marginal levels of skin cancer knowledge and engage minimally in sun protective behaviors. Skin cancer prevention interventions are warranted for this high-risk group, particularly in the locations in which Latino day laborers work.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2018-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/3454309","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信